Collegium Pharmaceutical Inc (COLL)
29.96
-0.45
(-1.48%)
USD |
NASDAQ |
Nov 22, 16:00
29.92
-0.04
(-0.13%)
After-Hours: 20:00
Collegium Pharmaceutical Revenue (TTM): 599.24M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 599.24M |
| June 30, 2024 | 576.65M |
| March 31, 2024 | 566.92M |
| December 31, 2023 | 566.77M |
| September 30, 2023 | 546.64M |
| June 30, 2023 | 536.95M |
| March 31, 2023 | 524.95M |
| December 31, 2022 | 463.93M |
| September 30, 2022 | 361.68M |
| June 30, 2022 | 313.50M |
| March 31, 2022 | 272.90M |
| December 31, 2021 | 276.87M |
| September 30, 2021 | 325.78M |
| June 30, 2021 | 326.11M |
| March 31, 2021 | 321.23M |
| Date | Value |
|---|---|
| December 31, 2020 | 310.02M |
| September 30, 2020 | 307.95M |
| June 30, 2020 | 301.71M |
| March 31, 2020 | 298.70M |
| December 31, 2019 | 296.70M |
| September 30, 2019 | 295.92M |
| June 30, 2019 | 293.16M |
| March 31, 2019 | 291.18M |
| December 31, 2018 | 280.41M |
| September 30, 2018 | 217.78M |
| June 30, 2018 | 159.55M |
| March 31, 2018 | 90.05M |
| December 31, 2017 | 28.48M |
| September 30, 2017 | 18.98M |
| June 30, 2017 | 7.443M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
272.90M
Minimum
Mar 2022
599.24M
Maximum
Sep 2024
404.76M
Average
325.94M
Median
Revenue (TTM) Benchmarks
| Amicus Therapeutics Inc | 493.67M |
| Insmed Inc | 342.96M |
| Pulmonx Corp | 79.30M |
| RxSight Inc | 128.29M |
| Context Therapeutics Inc | -- |